These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 24934384)

  • 1. Creatine for Parkinson's disease.
    Xiao Y; Luo M; Luo H; Wang J
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD009646. PubMed ID: 24934384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coenzyme Q10 for Parkinson's disease.
    Liu J; Wang L; Zhan SY; Xia Y
    Cochrane Database Syst Rev; 2011 Dec; (12):CD008150. PubMed ID: 22161420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WITHDRAWN: Coenzyme Q10 for Parkinson's disease.
    Liu J; Wang LN; Zhan SY; Xia Y
    Cochrane Database Syst Rev; 2012 May; 2012(5):CD008150. PubMed ID: 22592726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological interventions for the treatment of depression in chronic obstructive pulmonary disease.
    Pollok J; van Agteren JE; Carson-Chahhoud KV
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD012346. PubMed ID: 30566235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease.
    Rolinski M; Fox C; Maidment I; McShane R
    Cochrane Database Syst Rev; 2012 Mar; 2012(3):CD006504. PubMed ID: 22419314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment for memory disorder in multiple sclerosis.
    He D; Zhang Y; Dong S; Wang D; Gao X; Zhou H
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008876. PubMed ID: 24343792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine-derived n-3 fatty acids therapy for stroke.
    Alvarez Campano CG; Macleod MJ; Aucott L; Thies F
    Cochrane Database Syst Rev; 2019 Jun; 6(6):CD012815. PubMed ID: 31242320
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of faecal incontinence and constipation in adults with central neurological diseases.
    Coggrave M; Norton C
    Cochrane Database Syst Rev; 2013 Dec; (12):CD002115. PubMed ID: 24347087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treadmill training for patients with Parkinson's disease.
    Mehrholz J; Kugler J; Storch A; Pohl M; Hirsch K; Elsner B
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD007830. PubMed ID: 26363646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treadmill training for patients with Parkinson's disease.
    Mehrholz J; Kugler J; Storch A; Pohl M; Elsner B; Hirsch K
    Cochrane Database Syst Rev; 2015 Aug; (8):CD007830. PubMed ID: 26297797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine oxidase B inhibitors for early Parkinson's disease.
    Macleod AD; Counsell CE; Ives N; Stowe R
    Cochrane Database Syst Rev; 2005 Jul; 2005(3):CD004898. PubMed ID: 16034956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interventions for pityriasis rosea.
    Contreras-Ruiz J; Peternel S; Jiménez Gutiérrez C; Culav-Koscak I; Reveiz L; Silbermann-Reynoso ML
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684696
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interventions for necrotizing soft tissue infections in adults.
    Hua C; Bosc R; Sbidian E; De Prost N; Hughes C; Jabre P; Chosidow O; Le Cleach L
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011680. PubMed ID: 29851032
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-Analysis of Creatine for Neuroprotection Against Parkinson's Disease.
    Attia ; Ahmed H; Gadelkarim M; Morsi M; Awad K; Elnenny M; Ghanem E; El-Jaafary S; Negida A
    CNS Neurol Disord Drug Targets; 2017; 16(2):169-175. PubMed ID: 27823574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treadmill training for patients with Parkinson's disease.
    Mehrholz J; Friis R; Kugler J; Twork S; Storch A; Pohl M
    Cochrane Database Syst Rev; 2010 Jan; (1):CD007830. PubMed ID: 20091652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke.
    Sakai K; Yasufuku Y; Kamo T; Ota E; Momosaki R
    Cochrane Database Syst Rev; 2019 Nov; 11(11):CD011968. PubMed ID: 31784991
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effectiveness of creatine treatment for Parkinson's disease: an updated meta-analysis of randomized controlled trials.
    Mo JJ; Liu LY; Peng WB; Rao J; Liu Z; Cui LL
    BMC Neurol; 2017 Jun; 17(1):105. PubMed ID: 28577542
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug treatment for spinal muscular atrophy types II and III.
    Wadman RI; van der Pol WL; Bosboom WM; Asselman FL; van den Berg LH; Iannaccone ST; Vrancken AF
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD006282. PubMed ID: 32006461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Withdrawal or continuation of cholinesterase inhibitors or memantine or both, in people with dementia.
    Parsons C; Lim WY; Loy C; McGuinness B; Passmore P; Ward SA; Hughes C
    Cochrane Database Syst Rev; 2021 Feb; 2(2):CD009081. PubMed ID: 35608903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.